Literature DB >> 35471697

Association between levels of high-sensitivity C-reactive protein in plasma and freezing of gait in Parkinson's disease.

Jie Liu1,2, Weifang Yin1, Chuanbin Zhou1, Yangfan Zhu1,3, Meijuan Gu1,3, Bin Liu1,3, Hui Ren1,3, Xinglong Yang4,5.   

Abstract

This study explored the potential relationship between levels of high-sensitivity C-reactive protein (hs-CRP) in plasma and freezing of gait (FOG) in Parkinson's disease (PD) in China. A total of 72 healthy subjects, 62 PD patients with FOG, and 83 PD patients without FOG from our center were enrolled in this prospective study. Patients with FOG showed significantly higher hs-CRP levels than controls, but patients without FOG did not. Binary logistic regression analysis identified levels of hs-CRP in plasma to be an independent risk factor for FOG among the patients in our cohort (OR 6.371, 95% CI 2.589-15.678, p < 0.001). In fact, a cut-off level of 0.935 mg/L distinguished patients with or without FOG [area under the ROC curve (AUC) = 0.908, sensitivity 87.1%, specificity 89.2%]. Our study suggests that high levels of hs-CRP in plasma are associated with the occurrence of FOG in PD. The pooled data combined with a previous study carried out in Spain also indicate a positive association between plasma hs-CRP levels and FOG in PD. However, more research is still needed to verify the plasma hs-CRP as a potential biomarker of FOG.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Freezing of gait; High-sensitivity C-reactive protein; Parkinson’s disease; Risk factor

Mesh:

Substances:

Year:  2022        PMID: 35471697     DOI: 10.1007/s40520-022-02134-8

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   4.481


  40 in total

1.  High-sensitivity C-reactive protein and mobility disability in older adults.

Authors:  Joe Verghese; Roee Holtzer; Richard B Lipton; Cuiling Wang
Journal:  Age Ageing       Date:  2012-03-14       Impact factor: 10.668

Review 2.  MDS clinical diagnostic criteria for Parkinson's disease.

Authors:  Ronald B Postuma; Daniela Berg; Matthew Stern; Werner Poewe; C Warren Olanow; Wolfgang Oertel; José Obeso; Kenneth Marek; Irene Litvan; Anthony E Lang; Glenda Halliday; Christopher G Goetz; Thomas Gasser; Bruno Dubois; Piu Chan; Bastiaan R Bloem; Charles H Adler; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

3.  Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai.

Authors:  Zhen-Xin Zhang; Gustavo C Roman; Zhen Hong; Cheng-Bing Wu; Qiu-Ming Qu; Jue-Bing Huang; Bing Zhou; Zhi-Ping Geng; Ji-Xing Wu; Hong-Bo Wen; Heng Zhao; Gwendolyn E P Zahner
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

Review 4.  Acute-phase proteins and other systemic responses to inflammation.

Authors:  C Gabay; I Kushner
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

5.  Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson's disease? A comparison of Parkinson's disease patients, disease controls and healthy individuals.

Authors:  In-Uk Song; Joong-Seok Kim; Sung-Woo Chung; Kwang-Soo Lee
Journal:  Eur Neurol       Date:  2009-06-12       Impact factor: 1.710

Review 6.  Oxidative stress factors in Parkinson's disease.

Authors:  Jolanta Dorszewska; Marta Kowalska; Michał Prendecki; Thomas Piekut; Joanna Kozłowska; Wojciech Kozubski
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

7.  Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Zexu Wei; Xiaowan Li; Xixi Li; Qingshan Liu; Yong Cheng
Journal:  Front Mol Neurosci       Date:  2018-07-05       Impact factor: 5.639

Review 8.  The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases.

Authors:  Ying-Yi Luan; Yong-Ming Yao
Journal:  Front Immunol       Date:  2018-06-07       Impact factor: 7.561

9.  C-Reactive Protein and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Xiaohui Qiu; Yousheng Xiao; Jingjing Wu; Lu Gan; Yanning Huang; Jin Wang
Journal:  Front Neurol       Date:  2019-04-17       Impact factor: 4.003

10.  Parkinson's Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens.

Authors:  Büin Adams; J Massimo Nunes; Martin J Page; Timothy Roberts; Jonathan Carr; Theo A Nell; Douglas B Kell; Etheresia Pretorius
Journal:  Front Aging Neurosci       Date:  2019-08-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.